oseltamivir has been researched along with Allodynia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Souza Araújo, AA; Gasparotto, J; Gelain, DP; Guimarães, AG; Moreira, JCF; Oliveira, MA; Quintans-Júnior, LJ; Rabelo, TK; Serafini, MR | 1 |
| Crain, SM; Shen, KF | 1 |
2 other study(ies) available for oseltamivir and Allodynia
| Article | Year |
|---|---|
Shikimic acid inhibits LPS-induced cellular pro-inflammatory cytokines and attenuates mechanical hyperalgesia in mice.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antiviral Agents; Cytokines; Hyperalgesia; Immunity, Cellular; Inflammation Mediators; Lipopolysaccharides; Macrophages; Male; Mice; Oseltamivir; p38 Mitogen-Activated Protein Kinases; RAW 264.7 Cells; Shikimic Acid; Signal Transduction | 2016 |
Neuraminidase inhibitor, oseltamivir blocks GM1 ganglioside-regulated excitatory opioid receptor-mediated hyperalgesia, enhances opioid analgesia and attenuates tolerance in mice.
Topics: Acetamides; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Enzyme Inhibitors; G(M1) Ganglioside; Hyperalgesia; Male; Mice; Morphine; Neuraminidase; Neurons; Oseltamivir; Pain Measurement; Receptors, Opioid; Time Factors | 2004 |